vs
Side-by-side financial comparison of GREENE COUNTY BANCORP INC (GCBC) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
GREENE COUNTY BANCORP INC is the larger business by last-quarter revenue ($22.2M vs $18.3M, roughly 1.2× ROCKWELL MEDICAL, INC.). GREENE COUNTY BANCORP INC runs the higher net margin — 46.3% vs -3.0%, a 49.3% gap on every dollar of revenue. On growth, GREENE COUNTY BANCORP INC posted the faster year-over-year revenue change (23.8% vs -25.6%). GREENE COUNTY BANCORP INC produced more free cash flow last quarter ($6.2M vs $2.2M). Over the past eight quarters, GREENE COUNTY BANCORP INC's revenue compounded faster (18.9% CAGR vs -10.1%).
Bank of Greene County is an American federally-chartered savings bank headquartered in Catskill, NY. The bank's branches are located in the Upstate New York counties of Greene, Columbia, Albany, Ulster, and Rensselaer.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
GCBC vs RMTI — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $22.2M | $18.3M |
| Net Profit | $10.3M | $-554.0K |
| Gross Margin | — | 21.1% |
| Operating Margin | 52.0% | -2.2% |
| Net Margin | 46.3% | -3.0% |
| Revenue YoY | 23.8% | -25.6% |
| Net Profit YoY | 37.4% | 26.7% |
| EPS (diluted) | $0.60 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $22.2M | $18.3M | ||
| Q3 25 | $21.5M | $15.9M | ||
| Q2 25 | $20.5M | $16.1M | ||
| Q1 25 | $20.1M | $18.9M | ||
| Q4 24 | $17.9M | $24.7M | ||
| Q3 24 | $16.9M | $28.3M | ||
| Q2 24 | $16.6M | $25.8M | ||
| Q1 24 | $15.7M | $22.7M |
| Q4 25 | $10.3M | $-554.0K | ||
| Q3 25 | $8.9M | $-1.8M | ||
| Q2 25 | $9.3M | $-1.5M | ||
| Q1 25 | $8.1M | $-1.5M | ||
| Q4 24 | $7.5M | $-756.0K | ||
| Q3 24 | $6.3M | $1.7M | ||
| Q2 24 | $6.7M | $343.0K | ||
| Q1 24 | $5.9M | $-1.7M |
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% | ||
| Q1 24 | — | 13.5% |
| Q4 25 | 52.0% | -2.2% | ||
| Q3 25 | 47.4% | -9.9% | ||
| Q2 25 | 53.5% | -8.4% | ||
| Q1 25 | 44.6% | -7.2% | ||
| Q4 24 | 45.0% | -2.1% | ||
| Q3 24 | 39.6% | 6.8% | ||
| Q2 24 | 41.2% | 2.0% | ||
| Q1 24 | 39.4% | -5.8% |
| Q4 25 | 46.3% | -3.0% | ||
| Q3 25 | 41.2% | -11.0% | ||
| Q2 25 | 45.6% | -9.3% | ||
| Q1 25 | 40.1% | -8.0% | ||
| Q4 24 | 41.7% | -3.1% | ||
| Q3 24 | 37.1% | 5.9% | ||
| Q2 24 | 40.6% | 1.3% | ||
| Q1 24 | 37.3% | -7.6% |
| Q4 25 | $0.60 | $-0.01 | ||
| Q3 25 | $0.52 | $-0.05 | ||
| Q2 25 | $0.55 | $-0.05 | ||
| Q1 25 | $0.47 | $-0.04 | ||
| Q4 24 | $0.44 | $-0.02 | ||
| Q3 24 | $0.37 | $0.04 | ||
| Q2 24 | $0.39 | $0.01 | ||
| Q1 24 | $0.34 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $258.3M | $37.0M |
| Total Assets | $3.1B | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $10.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $12.5M | ||
| Q1 25 | $155.5M | $11.4M | ||
| Q4 24 | $166.4M | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | $190.4M | $11.9M | ||
| Q1 24 | — | $6.6M |
| Q4 25 | $258.3M | $37.0M | ||
| Q3 25 | $248.2M | $37.0M | ||
| Q2 25 | $238.8M | $30.4M | ||
| Q1 25 | $229.0M | $31.5M | ||
| Q4 24 | $218.4M | $32.6M | ||
| Q3 24 | $216.3M | $29.1M | ||
| Q2 24 | $206.0M | $23.5M | ||
| Q1 24 | $199.2M | $20.6M |
| Q4 25 | $3.1B | $57.1M | ||
| Q3 25 | $3.1B | $57.5M | ||
| Q2 25 | $3.0B | $52.6M | ||
| Q1 25 | $3.0B | $54.0M | ||
| Q4 24 | $3.0B | $59.2M | ||
| Q3 24 | $2.9B | $57.1M | ||
| Q2 24 | $2.8B | $53.0M | ||
| Q1 24 | $2.9B | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $6.4M | $2.3M |
| Free Cash FlowOCF − Capex | $6.2M | $2.2M |
| FCF MarginFCF / Revenue | 28.0% | 12.0% |
| Capex IntensityCapex / Revenue | 0.9% | 0.5% |
| Cash ConversionOCF / Net Profit | 0.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $47.3M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $6.4M | $2.3M | ||
| Q3 25 | $7.0M | $-1.3M | ||
| Q2 25 | $28.0M | $1.8M | ||
| Q1 25 | $7.3M | $-3.5M | ||
| Q4 24 | $5.3M | $865.0K | ||
| Q3 24 | $2.1M | $4.3M | ||
| Q2 24 | $24.9M | $1.4M | ||
| Q1 24 | $5.6M | $-2.4M |
| Q4 25 | $6.2M | $2.2M | ||
| Q3 25 | $6.5M | $-1.5M | ||
| Q2 25 | $27.3M | $1.7M | ||
| Q1 25 | $7.3M | $-3.5M | ||
| Q4 24 | $5.1M | $470.0K | ||
| Q3 24 | $2.0M | $4.1M | ||
| Q2 24 | $23.4M | $1.2M | ||
| Q1 24 | $4.9M | $-2.5M |
| Q4 25 | 28.0% | 12.0% | ||
| Q3 25 | 30.4% | -9.6% | ||
| Q2 25 | 133.3% | 10.5% | ||
| Q1 25 | 36.1% | -18.8% | ||
| Q4 24 | 28.6% | 1.9% | ||
| Q3 24 | 11.8% | 14.4% | ||
| Q2 24 | 141.2% | 4.5% | ||
| Q1 24 | 31.3% | -11.1% |
| Q4 25 | 0.9% | 0.5% | ||
| Q3 25 | 1.9% | 1.4% | ||
| Q2 25 | 3.4% | 1.0% | ||
| Q1 25 | 0.3% | 0.3% | ||
| Q4 24 | 1.0% | 1.6% | ||
| Q3 24 | 0.9% | 0.7% | ||
| Q2 24 | 9.1% | 1.1% | ||
| Q1 24 | 4.2% | 0.6% |
| Q4 25 | 0.62× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 3.00× | — | ||
| Q1 25 | 0.91× | — | ||
| Q4 24 | 0.71× | — | ||
| Q3 24 | 0.34× | 2.57× | ||
| Q2 24 | 3.70× | 4.20× | ||
| Q1 24 | 0.95× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GCBC
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |
